Posts Tagged ‘General Dynamics’

Electric Boat developing speedy sub for DARPA

Tuesday, July 28th, 2009

Connecticut newspaper the Day reports General Dynamics Electric Boat is working on a submarine that could travel submerged at about 100 knots, or about four times faster than the current fastest sub.

Electric Boat plans to test a version of the DARPA-funded sub off Rhode Island in early 2010:

The technology, if developed, could revolutionize ocean transportation if it could be adapted to cargo and passenger ships.

The vehicle would travel inside a large gas bubble created in the water, a process known as supercavitation. The bubble reduces drag, since the drag is much lower in air than in water, allowing the vehicle to travel at high speeds.

Supercavitation is not new. The technology has been applied to weapons, but never to transport vehicles, according to DARPA.

Finance Roundup: Oscient, Nexage, Delfigo

Tuesday, July 14th, 2009

 

New England Tech Stock Index

New England Tech Stock Index

Nexage moves in, Oscient files for bankruptcy and Delfigo partners with Children’s Hospital in today’s Finance Roundup. 

 

Oscient faces de-listing, files Ch. 11, sells Factive drug

Drug maker Oscient Pharmaceuticals Corp. filed for Chapter 11 bankruptcy protection yesterday, along with its wholly owned subsidiary, Guardian II Acquisition Corp. At the same time, Oscient is selling one of its two drugs, Factive, for more than $5 million.

Nexage raises $4M, plans move to Boston

 

California mobile advertising firm Nexage Inc. said it closed a first round of funding with $4 million and will move its headquarters from Fremont to Boston.
Nexage said the funding came from Wellesley-based GrandBanks Capital and BlackBerry Partners Fund of Canada.
Delfigo Corp., a Boston developer of authentication software, announced Tuesday the launch of its first product, DSGateway, and the signing of Children’s Hospital Boston as its first customer. (more…)

NewsFlash Roundup: AMAG, General Dynamics; Marine Renewable Energy Center

Wednesday, July 1st, 2009

In today’s NewsFlash Roundup, General Dynamics gets $10 million for grenade launchers and AMAG’s kidney drug gets FDA approval.

Boston life science center pulls in $350M loan

The center, which is intended to serve as a world-class research and collaboration hub for life sciences companies and the Harvard University-affiliated teaching hospitals, was completed last year. As of the beginning of 2009, the center was nearing its capacity.

AMAG wins FDA approval for kidney drug

AMAG Pharmaceuticals Inc. has won U.S. Food and Drug Administration approval for its drug, called Feraheme, to treat chronic kidney disease. The Lexington-based company’s drug is an injection designed to be used as an iron replacement therapy to fight anemia in patients with kidney disease. The drug can be used by patients who are on or off dialysis.

DOE awards $750K to Marine Renewable Energy Center

The center’s Marine Renewable Energy Center will receive $750,000 from the U.S. Department of Energy’s fiscal year 2010 budget, said John Miller, director of operations for the ATMC and head of the marine center. The appropriation is on top of $1 million in DOE grant funding the marine center will receive to spur academic research efforts and support small marine technology companies. (more…)

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.